WINDTREE THERAPEUTICS INC /DE/ Proceeds from Issuance or Sale of Equity
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Proceeds from Issuance or Sale of Equity of $10.80 million for the 1-month period ending 2023-04-30, per its 10-Q filed 2023-11-09.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOrSaleOfEquity · last filed 2025-04-15
- WINDTREE THERAPEUTICS INC /DE/ proceeds from issuance or sale of equity for the quarter ending 2018-12-31 was $30.35M, a 399.95% increase year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ proceeds from issuance or sale of equity for the quarter ending 2018-09-30 was $0.00.
- WINDTREE THERAPEUTICS INC /DE/ proceeds from issuance or sale of equity for the quarter ending 2017-12-31 was $6.07M.
- WINDTREE THERAPEUTICS INC /DE/ proceeds from issuance or sale of equity for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ proceeds from issuance or sale of equity for fiscal 2018 was $32.89M, a 121.35% increase from fiscal 2017.
- WINDTREE THERAPEUTICS INC /DE/ proceeds from issuance or sale of equity for fiscal 2017 was $14.86M.
- WINDTREE THERAPEUTICS INC /DE/ proceeds from issuance or sale of equity for fiscal 2015 was $32.63M.
- WINDTREE THERAPEUTICS INC /DE/ proceeds from issuance or sale of equity for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
| Period end | Proceeds from Issuance or Sale of Equity 0 month | Proceeds from Issuance or Sale of Equity | Proceeds from Issuance or Sale of Equity 1 month | Proceeds from Issuance or Sale of Equity 3 month | Proceeds from Issuance or Sale of Equity 6 month | Proceeds from Issuance or Sale of Equity 6 month as first filed | Proceeds from Issuance or Sale of Equity 9 month | Proceeds from Issuance or Sale of Equity 12 month |
|---|---|---|---|---|---|---|---|---|
| 2023-04-30 | $10.80M 10-Q · filed 2023-11-09 | |||||||
| 2023-04-24 | $10.80M 10-K · filed 2025-04-15 | |||||||
| 2021-03-25 | $27.40M 10-Q · filed 2021-05-13 | |||||||
| 2020-05-22 | $20.20M 10-Q · filed 2020-11-16 | |||||||
| 2018-12-31 | $30.35M derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-04-23 | $30.35M derived: sum of 2 quarters · filed 2019-11-14 | $32.89M 10-K/A · filed 2019-04-23 | |||||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $2.54M 10-Q · filed 2019-11-14 | ||||||
| 2018-06-30 | $2.54M 10-Q · filed 2019-08-14 | $2.54M 10-Q · filed 2018-08-14 | ||||||
| 2017-12-31 | $6.07M derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-04-23 | $6.07M derived: sum of 2 quarters · filed 2019-04-23 | $6.06M derived: sum of 3 quarters · filed 2019-04-23 | $14.86M 10-K/A · filed 2019-04-23 | ||||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$7.00K derived: sum of 2 quarters · filed 2018-11-14 | $8.79M 10-Q · filed 2018-11-14 | |||||
| 2017-06-30 | -$7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $8.79M 10-Q · filed 2018-08-14 | ||||||
| 2017-03-31 | $8.80M 10-Q · filed 2018-05-21 | |||||||
| 2016-12-31 | $709.00K 10-K · filed 2017-03-31 | |||||||
| 2016-09-30 | $402.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $471.00K 10-Q · filed 2016-11-14 | ||||||
| 2016-06-30 | $69.00K 10-Q · filed 2016-08-10 | |||||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $32.63M 10-K · filed 2017-03-31 | ||||||
| 2015-09-30 | $32.63M 10-Q · filed 2016-11-14 | |||||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $0.00 derived: sum of 2 quarters · filed 2016-03-29 | $0.00 10-K · filed 2016-03-29 | |||||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $0.00 10-Q · filed 2015-11-05 | ||||||
| 2014-06-30 | $0.00 10-Q · filed 2014-08-07 | |||||||
| 2013-12-31 | $55.66M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $55.66M derived: sum of 2 quarters · filed 2015-03-16 | $70.77M derived: sum of 3 quarters · filed 2015-03-16 | $70.77M 10-K · filed 2015-03-16 | ||||
| 2013-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $15.11M derived: sum of 2 quarters · filed 2014-11-07 | $15.11M 10-Q · filed 2014-11-07 | $15.06M derived: sum of 4 quarters · filed 2015-03-16 | ||||
| 2013-06-30 | $15.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $15.11M 10-Q · filed 2014-08-07 | $15.06M derived: sum of 3 quarters · filed 2015-03-16 | $15.06M derived: sum of 4 quarters · filed 2015-03-16 | ||||
| 2013-03-31 | $0.00 10-Q · filed 2013-05-07 | -$54.00K derived: sum of 2 quarters · filed 2015-03-16 | -$54.00K derived: sum of 3 quarters · filed 2015-03-16 | -$53.00K derived: sum of 4 quarters · filed 2015-03-16 | ||||
| 2012-12-31 | -$54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | -$54.00K derived: sum of 2 quarters · filed 2015-03-16 | -$53.00K derived: sum of 3 quarters · filed 2015-03-16 | $43.55M 10-K · filed 2015-03-16 | ||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $1.00K derived: sum of 2 quarters · filed 2013-11-12 | $43.60M 10-Q · filed 2013-11-12 | $43.95M derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2012-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $43.60M 10-Q · filed 2013-08-08 | $43.95M derived: sum of 3 quarters · filed 2014-03-17 | $43.95M derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2012-03-31 | $43.60M 10-Q · filed 2013-05-07 | $43.95M derived: sum of 2 quarters · filed 2014-03-17 | $43.95M derived: sum of 3 quarters · filed 2014-03-17 | $43.95M derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2011-12-31 | $344.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $344.00K derived: sum of 2 quarters · filed 2014-03-17 | $344.00K derived: sum of 3 quarters · filed 2014-03-17 | $22.93M 10-K · filed 2014-03-17 | ||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $0.00 derived: sum of 2 quarters · filed 2012-11-14 | $22.58M 10-Q · filed 2012-11-14 | $23.83M derived: sum of 4 quarters · filed 2013-03-15 | ||||
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $22.58M 10-Q · filed 2012-08-14 | $23.83M derived: sum of 3 quarters · filed 2013-03-15 | $24.31M derived: sum of 4 quarters · filed 2013-03-15 | ||||
| 2011-03-31 | $22.58M 10-Q · filed 2012-05-15 | $23.83M derived: sum of 2 quarters · filed 2013-03-15 | $24.31M derived: sum of 3 quarters · filed 2013-03-15 | |||||
| 2010-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $1.73M derived: sum of 2 quarters · filed 2013-03-15 | $27.98M 10-K · filed 2013-03-15 | |||||
| 2010-09-30 | $479.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $26.73M 10-Q · filed 2011-11-14 | ||||||
| 2010-06-30 | $26.25M 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |